| Skin AF ≤2.2 (n = 71) | Skin AF >2.2 (n = 68) | P value |
---|---|---|---|
Age (years) | 61.34 ± 11.34 | 66.57 ± 8.38 | 0.01 |
Gender (M/F) | 41/30 | 43/25 | 0.51 |
Skin AF (A.U.) | 1.90 ± 0.27 | 2.71 ± 0.31 | 0.01 |
BMI (kg/m2) | 26.50 ± 3.86 | 26.05 ± 3.25 | 0.74 |
SBP (mmHg) | 142.36 ± 14.83 | 139.06 ± 16.81 | 0.22 |
DBP (mmHg) | 80.80 ± 13.57 | 75.41 ± 9.46 | 0.01 |
PP (mmHg) | 61.92 ± 12.70 | 63.94 ± 14.64 | 0.39 |
Hypertension, n (%) | 59 (83.10) | 57 (83.82) | 0.91 |
DM, n (%) | Â | Â | 0.06 |
 None, n (%) | 50 (70.42) | 40 (58.82) |  |
 OHA, n (%) | 20 (28.17) | 21 (30.88) |  |
 RI, n (%) | 1 (1.41) | 7 (10.29) |  |
Hyperlipidemia, n (%) | 57 (80.28) | 52 (76.47) | 0.59 |
Stroke, n (%) | 3 (4.23) | 7 (10.29) | 0.17 |
IHD, n (%) | 9 (12.68) | 21 (30.88) | 0.01 |
PAOD, n (%) | 1 (1.41) | 1 (1.47) | 0.98 |
eGFR (mL/min/1.73 m2) | 66.64 ± 17.77 | 62.06 ± 22.73 | 0.19 |
Antiplatelets, n (%) | 48 (67.61) | 43 (63.24) | 0.59 |
β-Blockers, n (%) | 25 (35.21) | 34 (50.00) | 0.08 |
CCBs, n (%) | 29 (40.85) | 33 (48.53) | 0.36 |
ACEIs/ARBs, n (%) | 49 (69.01) | 43 (63.24) | 0.47 |
Statins, n (%) | 40 (56.34) | 41 (60.29) | 0.64 |
Smoking | Â | Â | 0.06 |
 Never, n (%) | 55 (77.46) | 40 (58.82) |  |
 Ever, n (%) | 10 (14.08) | 19 (27.94) |  |
 Active, n (%) | 6 (8.45) | 9 (13.24) |  |